These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 321297)

  • 21. [Clinical study of a new oral contraceptive: ovostat].
    Callaerts J; Demol R; Figoureux J; Kock E; Huyghebaert G
    Brux Med; 1973 Jul; 53(7):409-18. PubMed ID: 4582059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical experiences with femovan (Gynera)].
    Brill K; Düsterberg B; Albring M
    Ther Umsch; 1990 Dec; 47(12):958-65. PubMed ID: 2096480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of a novel norgestimate/ethinyl estradiol oral contraceptive (Ortho Tri-Cyclen Lo) with the oral contraceptive Loestrin Fe 1/20.
    Hampton RM; Short M; Bieber E; Bouchard C; Ayotte N; Shangold G; Fisher AC; Creasy GW
    Contraception; 2001 Jun; 63(6):289-95. PubMed ID: 11672549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Norethindrone acetate 1.0 milligram and ethinyl estradiol 10 micrograms as an ultra low-dose oral contraceptive.
    Archer DF; Nakajima ST; Sawyer AT; Wentworth J; Trupin S; Koltun WD; Gilbert RD; Ellman H
    Obstet Gynecol; 2013 Sep; 122(3):601-7. PubMed ID: 23921878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical experience with a new norgestimate-containing oral contraceptive.
    Huber J
    Int J Fertil; 1991; 36 Suppl 1():25-31. PubMed ID: 1678378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral contraceptives according to the normophasic principle.
    Borglin NE; Klottrup P
    Arzneimittelforschung; 1978; 28(12):2354-7. PubMed ID: 582954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Oral contraceptive agents and antithrombin III].
    Kamenov V; Nalbanski B
    Akush Ginekol (Sofiia); 1990; 29(1):60-3. PubMed ID: 1695492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early symptoms and discontinuation among users of oral contraceptives in Sri Lanka.
    Basnayake S; Higgins JE; Miller PC; Rogers SM; Kelly SE
    Stud Fam Plann; 1984; 15(6 Pt 1):285-90. PubMed ID: 6393460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Four years overall experience with a new low estrogen -- low progestogen oral contraceptive.
    Brat T
    Acta Obstet Gynecol Scand Suppl; 1976; 54():67-70. PubMed ID: 788448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Longterm study of a minipill consisting of 30 mcg ethinyl estradiol and 1 mg norethisterone acetate].
    Cohen J; Crouzette J
    Contracept Fertil Sex (Paris); 1976 Mar; 4(2):111-4. PubMed ID: 1261725
    [No Abstract]   [Full Text] [Related]  

  • 31. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
    Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
    Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three triphasic oral contraceptives now available in U.S.
    Contracept Technol Update; 1985 Jan; 6(1):1-2, 4. PubMed ID: 12279912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Changes in arterial blood pressure of women using hormonal contraceptives in relation to their cardiovascular history].
    Manuilova IA; Dubnitskaia LV; Korsakov SG
    Akush Ginekol (Mosk); 1989 Jul; (7):48-51. PubMed ID: 2478038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimum dosage of an oral contraceptive. A report from the study of seven combinations of norgestimate and ethinyl estradiol.
    Lawson JS; Yuliano SE; Pasquale SA; Osterman JJ
    Am J Obstet Gynecol; 1979 Jun; 134(3):315-20. PubMed ID: 377968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimal androgenic activity of a new oral contraceptive containing norethindrone acetate and graduated doses of ethinyl estradiol.
    Boyd RA; Zegarac EA; Posvar EL; Flack MR
    Contraception; 2001 Feb; 63(2):71-6. PubMed ID: 11292470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical use of combined contraceptive preparations of Hungarian manufacture].
    Farkas M
    Akush Ginekol (Mosk); 1983 Nov; (11):11-4. PubMed ID: 6364870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of a multicentre trial of a new low-dose oral contraceptive in Great Britain.
    Bye PG
    Acta Obstet Gynecol Scand Suppl; 1976; 54():61-6. PubMed ID: 788447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical results with a new low dose oral contraceptive utilizing norethindrone/ethinyl estradiol.
    Pasquale SA; Yuliano E
    Contraception; 1975 Nov; 12(5):495-503. PubMed ID: 1192736
    [No Abstract]   [Full Text] [Related]  

  • 39. Vaginal bleeding in postmenopausal women taking low-dose norethindrone acetate and ethinyl estradiol combinations. The FemHRT Study Investigators.
    Symons J; Kempfert N; Speroff L
    Obstet Gynecol; 2000 Sep; 96(3):366-72. PubMed ID: 10960627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alopecia related to low dose oral contraceptive.
    Yokoyama Y; Sato S; Saito Y
    Arch Gynecol Obstet; 2002 Jan; 266(1):46-7. PubMed ID: 11998965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.